PALATINE, Ill., Nov. 6 /PRNewswire/ -- Electrical industry leader
Square D / Schneider Electric has stepped up its support of the pharmaceutical
industry with the appointment of an international management team with deep
experience in the industry to oversee the company's global pharmaceutical
Global Marketing Manager Stephen Larson and Global Sales Directors Mark
Liston and Ian Job-Smith, who are based in the U.S. and Europe, respectively,
have been named to the new posts. They lead an international staff of
professionals in delivering a wide variety of product applications and
services to the pharmaceutical market, including engineered equipment
packages, embedded intelligence devices, software applications and a diverse
portfolio of engineering, analytical and diagnostic services.
"Creating a team that coordinates our support of the pharmaceutical
industry worldwide enables us to put Schneider Electric's considerable muscle
to work helping customers maximize the productivity of their assets and
people," said Larson, a former Schneider Global Strategic Account Manager.
Mark Liston, who served as Global Strategic Account Manager for Merck,
coordinated Schneider's support of Merck's domestic and international project
activity for the past four years. The relationship between the two companies
has influenced a number of Schneider's strategic initiatives in recent years,
including asset management, regulatory compliance and the development of
intelligent motor control centers.
"Our ability to leverage global resources to support customers seamlessly
across traditional geographical and cultural boundaries has been a significant
benefit to the pharmaceutical industry," Liston said. He pointed to Schneider
Electric's new competency center, which provides application and technical
resources to pharmaceutical customers, as one example of Schneider's far-
ranging initiatives in support of the industry.
Among the many products and services now being developed by Schneider in
conjunction with pharmaceutical customers are FDA certification services for
equipment, electronic validation documentation for 21 CFR Part 11 regulatory
compliance and factory automation systems that are both open and secure.
Ian Job-Smith, who coordinates Schneider's resources for European-based
pharmaceutical companies, also serves as Global Strategic Account Manager for
Glaxo-SmithKline. "Our value to pharmaceutical companies is Schneider's
ability to consistently provide a compliant solution, no matter where their
facilities are located in the world," said Job-Smith. "This consistent global
solution helps pharmaceutical customers reduce the cost of constructing and
managing their facilities."
Job-Smith has been involved with the pharmaceutical industry for the past
eight years. In addition to his experience with Glaxo-SmithKline, he has
worked with Astra-Zeneca and Novartis.
For more information about Schneider Electric solutions for the
pharmaceutical industry, call 1-800-392-8781, visit www.SquareD.com or
www.schneiderelectric.com or e-mail help@SquareDinfo.com.
Schneider Electric, the World's Power and Control Specialist, provides
electrical distribution, industrial control and automation products, systems
and services to customers in the energy, buildings, industrial and
infrastructure markets. With leading international brands such as MERLIN
GERIN, MODICON, SQUARE D and TELEMECANIQUE, Schneider Electric's
67,000 employees generated sales of approximately 9.7 billion Euro in 2000
through 9,000 sales outlets in 130 countries.
CONTACT: Jeanne Schweder of pricemcnabb, +1-704-916-6173, or
email@example.com, for Schneider Electric
MAKE YOUR OPINION COUNT - Click Here
SOURCE Schneider Electric